nodes	percent_of_prediction	percent_of_DWPC	metapath
Conivaptan—Infusion site pain—Capecitabine—colon cancer	0.0588	0.0618	CcSEcCtD
Conivaptan—Atrial arrhythmia—Capecitabine—colon cancer	0.0348	0.0365	CcSEcCtD
Conivaptan—Arrhythmia supraventricular—Capecitabine—colon cancer	0.0249	0.0261	CcSEcCtD
Conivaptan—Hypomagnesaemia—Irinotecan—colon cancer	0.0227	0.0238	CcSEcCtD
Conivaptan—Lomitapide—ABCB1—colon cancer	0.0205	0.43	CrCbGaD
Conivaptan—Tolvaptan—ABCB1—colon cancer	0.0182	0.383	CrCbGaD
Conivaptan—Hypomagnesaemia—Capecitabine—colon cancer	0.0152	0.016	CcSEcCtD
Conivaptan—Oral candidiasis—Capecitabine—colon cancer	0.0152	0.016	CcSEcCtD
Conivaptan—Pharyngolaryngeal pain—Capecitabine—colon cancer	0.0143	0.015	CcSEcCtD
Conivaptan—Laryngeal pain—Capecitabine—colon cancer	0.0142	0.0149	CcSEcCtD
Conivaptan—Urine output increased—Vincristine—colon cancer	0.0134	0.0141	CcSEcCtD
Conivaptan—Sepsis—Irinotecan—colon cancer	0.0125	0.0131	CcSEcCtD
Conivaptan—Polyuria—Vincristine—colon cancer	0.0122	0.0129	CcSEcCtD
Conivaptan—Sepsis—Fluorouracil—colon cancer	0.012	0.0126	CcSEcCtD
Conivaptan—Hyponatraemia—Vincristine—colon cancer	0.0108	0.0113	CcSEcCtD
Conivaptan—Hyponatraemia—Irinotecan—colon cancer	0.0105	0.011	CcSEcCtD
Conivaptan—Cardiac failure—Fluorouracil—colon cancer	0.0103	0.0108	CcSEcCtD
Conivaptan—Dehydration—Vincristine—colon cancer	0.01	0.0105	CcSEcCtD
Conivaptan—Dehydration—Irinotecan—colon cancer	0.00974	0.0102	CcSEcCtD
Conivaptan—Orthostatic hypotension—Irinotecan—colon cancer	0.00957	0.01	CcSEcCtD
Conivaptan—Hypokalaemia—Irinotecan—colon cancer	0.00953	0.01	CcSEcCtD
Conivaptan—Candida infection—Capecitabine—colon cancer	0.00922	0.00968	CcSEcCtD
Conivaptan—Atorvastatin—ABCB1—colon cancer	0.00891	0.187	CrCbGaD
Conivaptan—Urine output increased—Capecitabine—colon cancer	0.00873	0.00917	CcSEcCtD
Conivaptan—Sepsis—Capecitabine—colon cancer	0.00838	0.0088	CcSEcCtD
Conivaptan—Pneumonia—Vincristine—colon cancer	0.00834	0.00875	CcSEcCtD
Conivaptan—Phlebitis—Capecitabine—colon cancer	0.00814	0.00854	CcSEcCtD
Conivaptan—Pneumonia—Irinotecan—colon cancer	0.00812	0.00852	CcSEcCtD
Conivaptan—Polyuria—Capecitabine—colon cancer	0.00798	0.00838	CcSEcCtD
Conivaptan—Pneumonia—Fluorouracil—colon cancer	0.00777	0.00816	CcSEcCtD
Conivaptan—Infestation NOS—Fluorouracil—colon cancer	0.00773	0.00812	CcSEcCtD
Conivaptan—Infestation—Fluorouracil—colon cancer	0.00773	0.00812	CcSEcCtD
Conivaptan—Urinary tract infection—Fluorouracil—colon cancer	0.00751	0.00789	CcSEcCtD
Conivaptan—Atrial fibrillation—Capecitabine—colon cancer	0.0074	0.00777	CcSEcCtD
Conivaptan—Thirst—Capecitabine—colon cancer	0.00737	0.00773	CcSEcCtD
Conivaptan—Urinary tract disorder—Vincristine—colon cancer	0.00735	0.00771	CcSEcCtD
Conivaptan—Urethral disorder—Vincristine—colon cancer	0.00729	0.00766	CcSEcCtD
Conivaptan—Cardiac failure—Capecitabine—colon cancer	0.00718	0.00754	CcSEcCtD
Conivaptan—Hyponatraemia—Capecitabine—colon cancer	0.00704	0.00739	CcSEcCtD
Conivaptan—Cardiac disorder—Vincristine—colon cancer	0.0069	0.00725	CcSEcCtD
Conivaptan—Angiopathy—Vincristine—colon cancer	0.00675	0.00709	CcSEcCtD
Conivaptan—Cardiac disorder—Irinotecan—colon cancer	0.00672	0.00706	CcSEcCtD
Conivaptan—Mediastinal disorder—Vincristine—colon cancer	0.0067	0.00704	CcSEcCtD
Conivaptan—Angiopathy—Irinotecan—colon cancer	0.00657	0.0069	CcSEcCtD
Conivaptan—Mediastinal disorder—Irinotecan—colon cancer	0.00653	0.00686	CcSEcCtD
Conivaptan—Dehydration—Capecitabine—colon cancer	0.00652	0.00684	CcSEcCtD
Conivaptan—Mental disorder—Vincristine—colon cancer	0.00652	0.00684	CcSEcCtD
Conivaptan—Urine output increased—Methotrexate—colon cancer	0.0065	0.00682	CcSEcCtD
Conivaptan—Orthostatic hypotension—Capecitabine—colon cancer	0.0064	0.00672	CcSEcCtD
Conivaptan—Hypokalaemia—Capecitabine—colon cancer	0.00638	0.0067	CcSEcCtD
Conivaptan—Sepsis—Methotrexate—colon cancer	0.00624	0.00655	CcSEcCtD
Conivaptan—Erythema—Fluorouracil—colon cancer	0.00604	0.00634	CcSEcCtD
Conivaptan—Anaemia—Vincristine—colon cancer	0.00599	0.00629	CcSEcCtD
Conivaptan—Polyuria—Methotrexate—colon cancer	0.00594	0.00624	CcSEcCtD
Conivaptan—Anaemia—Irinotecan—colon cancer	0.00583	0.00612	CcSEcCtD
Conivaptan—Hypertension—Vincristine—colon cancer	0.00559	0.00587	CcSEcCtD
Conivaptan—Anaemia—Fluorouracil—colon cancer	0.00558	0.00586	CcSEcCtD
Conivaptan—Hyperglycaemia—Capecitabine—colon cancer	0.00546	0.00574	CcSEcCtD
Conivaptan—Hypertension—Irinotecan—colon cancer	0.00545	0.00572	CcSEcCtD
Conivaptan—Pneumonia—Capecitabine—colon cancer	0.00543	0.0057	CcSEcCtD
Conivaptan—Infestation—Capecitabine—colon cancer	0.0054	0.00567	CcSEcCtD
Conivaptan—Infestation NOS—Capecitabine—colon cancer	0.0054	0.00567	CcSEcCtD
Conivaptan—Infection—Vincristine—colon cancer	0.00525	0.00551	CcSEcCtD
Conivaptan—Urinary tract infection—Capecitabine—colon cancer	0.00525	0.00551	CcSEcCtD
Conivaptan—Confusional state—Irinotecan—colon cancer	0.00519	0.00545	CcSEcCtD
Conivaptan—Nervous system disorder—Vincristine—colon cancer	0.00518	0.00544	CcSEcCtD
Conivaptan—Haematuria—Capecitabine—colon cancer	0.00515	0.00541	CcSEcCtD
Conivaptan—Infection—Irinotecan—colon cancer	0.00511	0.00537	CcSEcCtD
Conivaptan—Nervous system disorder—Irinotecan—colon cancer	0.00505	0.0053	CcSEcCtD
Conivaptan—Confusional state—Fluorouracil—colon cancer	0.00497	0.00522	CcSEcCtD
Conivaptan—Hypotension—Vincristine—colon cancer	0.00494	0.00519	CcSEcCtD
Conivaptan—Infection—Fluorouracil—colon cancer	0.0049	0.00514	CcSEcCtD
Conivaptan—Nervous system disorder—Fluorouracil—colon cancer	0.00483	0.00508	CcSEcCtD
Conivaptan—Hypotension—Irinotecan—colon cancer	0.00481	0.00505	CcSEcCtD
Conivaptan—Urinary tract disorder—Capecitabine—colon cancer	0.00479	0.00503	CcSEcCtD
Conivaptan—Insomnia—Vincristine—colon cancer	0.00478	0.00502	CcSEcCtD
Conivaptan—Oedema peripheral—Capecitabine—colon cancer	0.00478	0.00502	CcSEcCtD
Conivaptan—Urethral disorder—Capecitabine—colon cancer	0.00475	0.00499	CcSEcCtD
Conivaptan—Insomnia—Irinotecan—colon cancer	0.00466	0.00489	CcSEcCtD
Conivaptan—Hypotension—Fluorouracil—colon cancer	0.00461	0.00484	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Vincristine—colon cancer	0.00456	0.00479	CcSEcCtD
Conivaptan—Pain—Vincristine—colon cancer	0.00452	0.00475	CcSEcCtD
Conivaptan—Constipation—Vincristine—colon cancer	0.00452	0.00475	CcSEcCtD
Conivaptan—Cardiac disorder—Capecitabine—colon cancer	0.0045	0.00473	CcSEcCtD
Conivaptan—Insomnia—Fluorouracil—colon cancer	0.00446	0.00468	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Irinotecan—colon cancer	0.00444	0.00467	CcSEcCtD
Conivaptan—Pain—Irinotecan—colon cancer	0.0044	0.00462	CcSEcCtD
Conivaptan—Constipation—Irinotecan—colon cancer	0.0044	0.00462	CcSEcCtD
Conivaptan—Angiopathy—Capecitabine—colon cancer	0.0044	0.00462	CcSEcCtD
Conivaptan—Mediastinal disorder—Capecitabine—colon cancer	0.00437	0.00459	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00426	0.00447	CcSEcCtD
Conivaptan—Mental disorder—Capecitabine—colon cancer	0.00425	0.00446	CcSEcCtD
Conivaptan—Feeling abnormal—Irinotecan—colon cancer	0.00424	0.00445	CcSEcCtD
Conivaptan—Erythema—Capecitabine—colon cancer	0.00422	0.00443	CcSEcCtD
Conivaptan—Malnutrition—Capecitabine—colon cancer	0.00422	0.00443	CcSEcCtD
Conivaptan—Pain—Fluorouracil—colon cancer	0.00422	0.00443	CcSEcCtD
Conivaptan—Body temperature increased—Vincristine—colon cancer	0.00418	0.00439	CcSEcCtD
Conivaptan—Body temperature increased—Irinotecan—colon cancer	0.00407	0.00427	CcSEcCtD
Conivaptan—Feeling abnormal—Fluorouracil—colon cancer	0.00406	0.00427	CcSEcCtD
Conivaptan—Pneumonia—Methotrexate—colon cancer	0.00404	0.00425	CcSEcCtD
Conivaptan—Infestation—Methotrexate—colon cancer	0.00402	0.00422	CcSEcCtD
Conivaptan—Infestation NOS—Methotrexate—colon cancer	0.00402	0.00422	CcSEcCtD
Conivaptan—Anaemia—Capecitabine—colon cancer	0.0039	0.0041	CcSEcCtD
Conivaptan—Body temperature increased—Fluorouracil—colon cancer	0.0039	0.00409	CcSEcCtD
Conivaptan—Haematuria—Methotrexate—colon cancer	0.00383	0.00403	CcSEcCtD
Conivaptan—Hypertension—Capecitabine—colon cancer	0.00364	0.00383	CcSEcCtD
Conivaptan—Diarrhoea—Vincristine—colon cancer	0.00362	0.0038	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.00357	0.00375	CcSEcCtD
Conivaptan—Urinary tract disorder—Methotrexate—colon cancer	0.00356	0.00374	CcSEcCtD
Conivaptan—Urethral disorder—Methotrexate—colon cancer	0.00354	0.00372	CcSEcCtD
Conivaptan—Diarrhoea—Irinotecan—colon cancer	0.00352	0.0037	CcSEcCtD
Conivaptan—Dry mouth—Capecitabine—colon cancer	0.00351	0.00369	CcSEcCtD
Conivaptan—Pruritus—Fluorouracil—colon cancer	0.00349	0.00366	CcSEcCtD
Conivaptan—Confusional state—Capecitabine—colon cancer	0.00347	0.00365	CcSEcCtD
Conivaptan—Infection—Capecitabine—colon cancer	0.00342	0.00359	CcSEcCtD
Conivaptan—Nervous system disorder—Capecitabine—colon cancer	0.00338	0.00355	CcSEcCtD
Conivaptan—Diarrhoea—Fluorouracil—colon cancer	0.00337	0.00354	CcSEcCtD
Conivaptan—Vomiting—Vincristine—colon cancer	0.00336	0.00353	CcSEcCtD
Conivaptan—Cardiac disorder—Methotrexate—colon cancer	0.00335	0.00352	CcSEcCtD
Conivaptan—Skin disorder—Capecitabine—colon cancer	0.00335	0.00351	CcSEcCtD
Conivaptan—Headache—Vincristine—colon cancer	0.00331	0.00348	CcSEcCtD
Conivaptan—Angiopathy—Methotrexate—colon cancer	0.00328	0.00344	CcSEcCtD
Conivaptan—Vomiting—Irinotecan—colon cancer	0.00327	0.00344	CcSEcCtD
Conivaptan—Mediastinal disorder—Methotrexate—colon cancer	0.00325	0.00342	CcSEcCtD
Conivaptan—Headache—Irinotecan—colon cancer	0.00322	0.00339	CcSEcCtD
Conivaptan—Hypotension—Capecitabine—colon cancer	0.00322	0.00338	CcSEcCtD
Conivaptan—Mental disorder—Methotrexate—colon cancer	0.00316	0.00332	CcSEcCtD
Conivaptan—Malnutrition—Methotrexate—colon cancer	0.00314	0.0033	CcSEcCtD
Conivaptan—Erythema—Methotrexate—colon cancer	0.00314	0.0033	CcSEcCtD
Conivaptan—Nausea—Vincristine—colon cancer	0.00314	0.0033	CcSEcCtD
Conivaptan—Vomiting—Fluorouracil—colon cancer	0.00313	0.00329	CcSEcCtD
Conivaptan—Insomnia—Capecitabine—colon cancer	0.00312	0.00327	CcSEcCtD
Conivaptan—Headache—Fluorouracil—colon cancer	0.00309	0.00324	CcSEcCtD
Conivaptan—Nausea—Irinotecan—colon cancer	0.00306	0.00321	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Capecitabine—colon cancer	0.00297	0.00312	CcSEcCtD
Conivaptan—Constipation—Capecitabine—colon cancer	0.00295	0.00309	CcSEcCtD
Conivaptan—Pain—Capecitabine—colon cancer	0.00295	0.00309	CcSEcCtD
Conivaptan—Nausea—Fluorouracil—colon cancer	0.00293	0.00307	CcSEcCtD
Conivaptan—Anaemia—Methotrexate—colon cancer	0.0029	0.00305	CcSEcCtD
Conivaptan—Feeling abnormal—Capecitabine—colon cancer	0.00284	0.00298	CcSEcCtD
Conivaptan—Body temperature increased—Capecitabine—colon cancer	0.00272	0.00286	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.00266	0.00279	CcSEcCtD
Conivaptan—Confusional state—Methotrexate—colon cancer	0.00259	0.00272	CcSEcCtD
Conivaptan—Infection—Methotrexate—colon cancer	0.00255	0.00268	CcSEcCtD
Conivaptan—Nervous system disorder—Methotrexate—colon cancer	0.00252	0.00264	CcSEcCtD
Conivaptan—Skin disorder—Methotrexate—colon cancer	0.00249	0.00262	CcSEcCtD
Conivaptan—Pruritus—Capecitabine—colon cancer	0.00244	0.00256	CcSEcCtD
Conivaptan—Hypotension—Methotrexate—colon cancer	0.0024	0.00252	CcSEcCtD
Conivaptan—Diarrhoea—Capecitabine—colon cancer	0.00236	0.00248	CcSEcCtD
Conivaptan—Insomnia—Methotrexate—colon cancer	0.00232	0.00244	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Methotrexate—colon cancer	0.00221	0.00232	CcSEcCtD
Conivaptan—Pain—Methotrexate—colon cancer	0.00219	0.0023	CcSEcCtD
Conivaptan—Vomiting—Capecitabine—colon cancer	0.00219	0.0023	CcSEcCtD
Conivaptan—Headache—Capecitabine—colon cancer	0.00216	0.00227	CcSEcCtD
Conivaptan—Feeling abnormal—Methotrexate—colon cancer	0.00211	0.00222	CcSEcCtD
Conivaptan—Nausea—Capecitabine—colon cancer	0.00205	0.00215	CcSEcCtD
Conivaptan—Body temperature increased—Methotrexate—colon cancer	0.00203	0.00213	CcSEcCtD
Conivaptan—Pruritus—Methotrexate—colon cancer	0.00181	0.00191	CcSEcCtD
Conivaptan—Diarrhoea—Methotrexate—colon cancer	0.00175	0.00184	CcSEcCtD
Conivaptan—Vomiting—Methotrexate—colon cancer	0.00163	0.00171	CcSEcCtD
Conivaptan—Headache—Methotrexate—colon cancer	0.00161	0.00169	CcSEcCtD
Conivaptan—Nausea—Methotrexate—colon cancer	0.00152	0.0016	CcSEcCtD
